Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News

May 2010

Dental News Roundup May 2010 BY LAUREN UZDIENSKI, MAY 28, 2010

NADX's go-shop period ends . . . Smile Brands cancels its IPO . . . Sirona launches new products . . . Straumann receives award for Roxolid . . . Regenerating teeth from stem cells more

Musculoskeletal News Roundup 27-May-10 BY LAUREN UZDIENSKI, MAY 27, 2010

Medtronic announces FQ4 . . . Exactech acquires Brighton Partners, supplier of Optetrak knee material . . . VentureMD closes funding round . . . KFx cleared to market AppianFx knee products . . . X-spine receives FDA clearance for Fixcet Spinal Facet Screw System . . . Applied Spine awarded patents . . . DFine, Vertos release clinical data . . . curasan collaborates with Matricel on bone graft substitute . . . SpineGuard appoints Alan Olsen Chairman of the Board more

UK Identifies Higher-than-Anticipated Revision Rate for DePuy's ASR BY LAUREN UZDIENSKI, MAY 26, 2010

ASR.pngCiting registry data, the UK released a medical device alert noting that DePuy's ASR acetabular cups have a higher-than-expected revision rate. While regulators anticipated a revision rate of about 3%, the actual rate has been closer to 4-5%. In addition to the registry data, two of the UK clinical sites that implant the device have echoed the higher failure rate. DePuy has been marketing the device in the UK since 2003. more

FDA May Make Application Info Public BY LAUREN UZDIENSKI, MAY 25, 2010

Per the recommendations of a transparency task force, a wider range of information about drug and device applications may become publicly available. Currently, the FDA only makes approvals public; an exception is made for applications that call for a panel recommendation, and of course some companies provide updates on their FDA filing status. more

Michigan Scientist Develops New Nanotube Coating for Implants BY LAUREN UZDIENSKI, MAY 20, 2010

A Michigan Tech Ph.D. candidate may have discovered a less expensive way to roughen the surface of titanium medical devices. Cells don't adhere to the smooth surface of untreated titanium, so devices are typically treated to give them a rougher surface before implantation. Instead of etching platinum into a device surface, which can cost $1,700 per ounce, Tolou Shokufar has devised a way of anodizing the material using a titanium alloy and copper. more

Musculoskeletal News Roundup 20-May-10 BY LAUREN UZDIENSKI, MAY 20, 2010

ANIK, SYK resolve FDA warning letters . . . FDA clears Mesoblast Phase II study . . . DePuy Mitek to launch Bristow-Latarjet Instability Shoulder System . . . OrthoX developing new bone cement . . . DOJ recovers $20 million in allegedly fraudulent kyphoplasty billings . . . SpineGuard signs European distributor . . . B1 collaborating with Invibio more

MA Law Would Require Physicians to Participate in Government Health Programs BY LAUREN UZDIENSKI, MAY 19, 2010

785px-Doctors_stethoscope_1.jpgA new bill proposed by the Massachusetts state legislature would force physicians to participate in Medicare, Medicaid and state health programs as a condition of licensure. The law would set physician pay at 110% of the Medicare reimbursement rate, which could pose financial hurdles for physicians in private practice. more

Jeffrey Shuren to Host CDRH Town Hall Meetings BY LAUREN UZDIENSKI, MAY 18, 2010

ucm195424.pngToday CDRH director Jeffrey Shuren will host a town hall meeting in Bloomington, Minnesota. On the agenda is an overview of the device group's 2010 priorities, but Shuren is also looking to get feedback from the device industry and the public.

Future town hall meetings will be held in Boston on June 22nd and Los Angeles in October. more

Health Reform Costs to Top $1 Trillion on "Discretionary" Spend BY LAUREN UZDIENSKI, MAY 13, 2010

USCurrency_Federal_Reserve_SMALL.jpgPresident Obama was adamant in the weeks leading up to the healthcare reform vote that costs would not exceed $1 trillion over a decade. The package passed at a projected spend of $940 billion, but now the CBO is expecting the overhaul to cost at least another $115 billion. The additional costs reflect administrative expenses and other "discretionary" funding measures to be approved by Congress at future dates. more

Musculoskeletal News Roundup 13-May-2010 BY LAUREN UZDIENSKI, MAY 13, 2010

aap Implantate, ATEC, ANIK, BMTI, OSTE report Q1 earnings . . . SBi announces Olympus investment . . . Aesculap launches pedicle screw system . . . data on B Braun's Targon screw . . . BioSyntech files for bankruptcy more

"Scorecard" for Device Markets Forthcoming from PWC BY LAUREN UZDIENSKI, MAY 12, 2010

pwc.gifPricewaterhouseCoopers announced that they're working on an "independent study of international market conditions for medical device innovation" in the key markets of Brazil, China, France, Germany, Israel, India, Japan, United Kingdom and the United States. PWC will score each region's device climate based on regulatory policy, patient access to technologies, demographics and "market factors." more

New iPhone App for the Orthopedic and Dental Industry (and via Kindle, too!) BY EDITOR, MAY 11, 2010

We're giving our readers two new ways to get news: through our new iPhone app, and via Kindle. Click for a FAQ on our new iPhone app and Kindle distribution. more

Alphatec Spine Adds New Vice President and General Manager, Latin America BY EDITOR, MAY 6, 2010

Armin Weichert Brings Over 25 Years of Sales and Management Experience in Medical Device and Life Sciences Industries CARLSBAD, Calif., May 5, 2010 (GlobeNewswire via COMTEX News Network) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc.,... more

Musculoskeletal News Roundup 6-May-2010 BY EDITOR, MAY 6, 2010

Earnings ArthroCare reported 1Q:10 revenues of $90.6 million, up 15% over the year-ago period and beating estimates by $5.0 million. Among the company's orthopedics division, sports medicine sales were $60.4 million and spine sales were $4.4 million. Net income for... more

Alphatec Spine Appoints New Vice President of Clinical, Quality and Regulatory BY EDITOR, MAY 5, 2010

Michael J. Sarrasin Brings Over 20 Years of Clinical, Quality Assurance and Regulatory Experience in Medical Device and Life Sciences Industries CARLSBAD, Calif., May 4, 2010 (GlobeNewswire via COMTEX News Network) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of... more

Musculoskeletal Industry on the Rebound in Q1 BY LAUREN UZDIENSKI, MAY 3, 2010

With financial results from 1Q:10 largely reported, there are signs of a rebound in the musculoskeletal industry. We estimate that the industry is growing at a rate of about 7%, accelerating from 4Q:09. With the largest shareholders reported, we estimate... more

Complete Archive